Glen Santangelo
Stock Analyst at Jefferies
(2.37)
# 1,349
Out of 4,479 analysts
59
Total ratings
48.72%
Success rate
-2.62%
Average return
Main Sectors:
34 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $21.21 | +8.44% | 4 | Jun 27, 2024 | |
TEVA Teva Pharmaceutical | Maintains: Buy | $19 → $23 | $16.55 | +38.97% | 4 | Jun 27, 2024 | |
COLL Collegium Pharmaceutical | Upgrades: Buy | $41 → $44 | $32.04 | +37.33% | 3 | Jun 7, 2024 | |
ELAN Elanco Animal Health | Initiates: Buy | $17 | $14.01 | +21.34% | 1 | Dec 19, 2023 | |
ZTS Zoetis | Assumes: Buy | $230 | $174.81 | +31.57% | 1 | Dec 19, 2023 | |
VRCA Verrica Pharmaceuticals | Reiterates: Buy | $10 | $7.47 | +33.87% | 2 | Dec 15, 2023 | |
AMPH Amphastar Pharmaceuticals | Reinstates: Buy | $70 | $37.58 | +86.27% | 2 | Jul 25, 2023 | |
ACCD Accolade | Downgrades: Hold | $14 | $3.53 | +296.60% | 2 | Feb 9, 2023 | |
VTRS Viatris | Upgrades: Buy | $13 → $15 | $10.43 | +43.82% | 2 | Jan 27, 2023 | |
SLGL Sol-Gel Technologies | Initiates: Hold | $5.5 | $0.92 | +498.28% | 1 | Oct 21, 2022 | |
XERS Xeris Biopharma Holdings | Assumes: Buy | $4 | $2.06 | +94.17% | 1 | Oct 21, 2022 | |
PHAT Phathom Pharmaceuticals | Initiates: Buy | $16 | $10.25 | +56.10% | 1 | Oct 21, 2022 | |
SCPH scPharmaceuticals | Assumes: Buy | $14 | $4.21 | +232.54% | 1 | Oct 21, 2022 | |
OPTN OptiNose | Assumes: Buy | $5 | $1.04 | +380.77% | 1 | Oct 21, 2022 | |
PCRX Pacira BioSciences | Assumes: Buy | $66 | $22.74 | +190.24% | 1 | Oct 21, 2022 | |
DOCS Doximity | Maintains: Buy | $78 → $46 | $26.96 | +70.62% | 2 | May 18, 2022 | |
HQY HealthEquity | Maintains: Buy | $62 → $80 | $85.76 | -6.72% | 2 | Mar 28, 2022 | |
HCAT Health Catalyst | Upgrades: Buy | $31 → $28 | $6.10 | +359.02% | 2 | Mar 17, 2022 | |
TDOC Teladoc Health | Maintains: Hold | $113 → $82 | $9.40 | +772.34% | 4 | Feb 7, 2022 | |
PHR Phreesia | Initiates: Buy | n/a | $20.50 | - | 1 | Dec 2, 2021 | |
AMWL American Well | Initiates: Hold | n/a | $0.30 | - | 2 | Dec 2, 2021 | |
PGNY Progyny | Initiates: Buy | n/a | $28.33 | - | 3 | Dec 2, 2021 | |
TALK Talkspace | Initiates: Hold | n/a | $2.18 | - | 1 | Dec 2, 2021 | |
GDRX GoodRx Holdings | Initiates: Buy | n/a | $7.82 | - | 1 | Dec 2, 2021 | |
RCM R1 RCM | Initiates: Buy | n/a | $10.90 | - | 1 | Dec 2, 2021 | |
DH Definitive Healthcare | Initiates: Buy | n/a | $5.43 | - | 1 | Dec 2, 2021 | |
CVS CVS Health | Downgrades: Neutral | n/a | $57.52 | - | 2 | Mar 17, 2021 | |
PDCO Patterson Companies | Upgrades: Buy | n/a | $23.92 | - | 1 | Jan 7, 2020 | |
CAH Cardinal Health | Downgrades: Neutral | n/a | $96.54 | - | 2 | Dec 16, 2019 | |
MCK McKesson | Upgrades: Hold | n/a | $584.83 | - | 2 | Jan 25, 2019 | |
HSIC Henry Schein | Maintains: Buy | n/a | $65.60 | - | 2 | Apr 24, 2018 | |
XRAY DENTSPLY SIRONA | Initiates: Buy | n/a | $24.44 | - | 1 | Dec 8, 2017 | |
ALGN Align Technology | Initiates: Hold | n/a | $239.74 | - | 1 | Dec 8, 2017 | |
WBA Walgreens Boots Alliance | Initiates: Hold | n/a | $11.57 | - | 1 | Dec 4, 2017 |
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $21.21
Upside: +8.44%
Teva Pharmaceutical
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $16.55
Upside: +38.97%
Collegium Pharmaceutical
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $32.04
Upside: +37.33%
Elanco Animal Health
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $14.01
Upside: +21.34%
Zoetis
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $174.81
Upside: +31.57%
Verrica Pharmaceuticals
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $7.47
Upside: +33.87%
Amphastar Pharmaceuticals
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $37.58
Upside: +86.27%
Accolade
Feb 9, 2023
Downgrades: Hold
Price Target: $14
Current: $3.53
Upside: +296.60%
Viatris
Jan 27, 2023
Upgrades: Buy
Price Target: $13 → $15
Current: $10.43
Upside: +43.82%
Sol-Gel Technologies
Oct 21, 2022
Initiates: Hold
Price Target: $5.5
Current: $0.92
Upside: +498.28%
Xeris Biopharma Holdings
Oct 21, 2022
Assumes: Buy
Price Target: $4
Current: $2.06
Upside: +94.17%
Phathom Pharmaceuticals
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $10.25
Upside: +56.10%
scPharmaceuticals
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $4.21
Upside: +232.54%
OptiNose
Oct 21, 2022
Assumes: Buy
Price Target: $5
Current: $1.04
Upside: +380.77%
Pacira BioSciences
Oct 21, 2022
Assumes: Buy
Price Target: $66
Current: $22.74
Upside: +190.24%
Doximity
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $26.96
Upside: +70.62%
HealthEquity
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $85.76
Upside: -6.72%
Health Catalyst
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $6.10
Upside: +359.02%
Teladoc Health
Feb 7, 2022
Maintains: Hold
Price Target: $113 → $82
Current: $9.40
Upside: +772.34%
Phreesia
Dec 2, 2021
Initiates: Buy
Price Target: n/a
Current: $20.50
Upside: -
American Well
Dec 2, 2021
Initiates: Hold
Price Target: n/a
Current: $0.30
Upside: -
Progyny
Dec 2, 2021
Initiates: Buy
Price Target: n/a
Current: $28.33
Upside: -
Talkspace
Dec 2, 2021
Initiates: Hold
Price Target: n/a
Current: $2.18
Upside: -
GoodRx Holdings
Dec 2, 2021
Initiates: Buy
Price Target: n/a
Current: $7.82
Upside: -
R1 RCM
Dec 2, 2021
Initiates: Buy
Price Target: n/a
Current: $10.90
Upside: -
Definitive Healthcare
Dec 2, 2021
Initiates: Buy
Price Target: n/a
Current: $5.43
Upside: -
CVS Health
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $57.52
Upside: -
Patterson Companies
Jan 7, 2020
Upgrades: Buy
Price Target: n/a
Current: $23.92
Upside: -
Cardinal Health
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $96.54
Upside: -
McKesson
Jan 25, 2019
Upgrades: Hold
Price Target: n/a
Current: $584.83
Upside: -
Henry Schein
Apr 24, 2018
Maintains: Buy
Price Target: n/a
Current: $65.60
Upside: -
DENTSPLY SIRONA
Dec 8, 2017
Initiates: Buy
Price Target: n/a
Current: $24.44
Upside: -
Align Technology
Dec 8, 2017
Initiates: Hold
Price Target: n/a
Current: $239.74
Upside: -
Walgreens Boots Alliance
Dec 4, 2017
Initiates: Hold
Price Target: n/a
Current: $11.57
Upside: -